Biography:
Dr. Eriko Padron-Regalado has a Ph.D. in vaccine design from the University of Oxford and graduated in 2020. He then joined the Vaccine Immunology group of the Division of Viral Diseases of the U.S. Centers for Disease Control and Prevention (CDC) as a research fellow. He has a Master´s degree in molecular epidemiology from the King Abdullah University of Science and Technology (KAUST, Saudi Arabia). Among other accomplishments, he helped to characterize the vaccine platform called ChAdOx1, which was later exploited for the COVID-19 AstraZeneca-Oxford vaccine. Overall, he has worked in academia, government and industry, both national and international, strengthening vaccine development, evaluation and approval. Currently, his scientific publications have an average citation of 100 citations per paper.
Title : Informatics approach to assess mumps vaccination